Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
Abroad (travel likely)RecruitingPHASE2
Conditions
Graft Versus Host Disease · Hematologic Malignancy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Angers, Angers, France
CHU Brest, Brest, France
Contact: Study coordinator (Marie-Anne COUTURIER, MD) · marie-anne.couturier@chu-brest.fr · 0298223765CHU Nantes, Nantes, France
Contact: Study coordinator (Amandine LE BOURGEOIS, MD) · amandine.lebourgeois@chu-nantes.fr · 0240083271
Study leads
Sylvain THEPOT, MD
Principal Investigator
University Hospital, Angers
Marie-Anne COUTURIER, MD
Principal Investigator
University Hospital, Brest